Skip to content

Clinical trials

Phase 1/2 Glioblastoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1/2 Country / region: Canada Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20101
20152
20181
20203
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AHS Cancer Control Alberta2
Radiation Therapy Oncology Group2
Celgene1
InSightec1
Karyopharm Therapeutics Inc1
LigaChem Biosciences, Inc.1
National Cancer Institute (NCI)1
Sumitomo Pharma America, Inc.1
Turning Point Therapeutics, Inc.1
Université de Sherbrooke1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma12
Glioma4
Gliosarcoma4
Central Nervous System Neoplasms3
Brain Neoplasms2
Anus Neoplasms1
Breast Neoplasms1
Endometrial Neoplasms1
Granuloma, Plasma Cell1
Head and Neck Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.